Lewis Asset Management, LLC Intellia Therapeutics, Inc. Transaction History
Lewis Asset Management, LLC
- $121 Billion
- Q1 2024
A detailed history of Lewis Asset Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Lewis Asset Management, LLC holds 30,593 shares of NTLA stock, worth $810,714. This represents 0.69% of its overall portfolio holdings.
Number of Shares
30,593
Previous 23,103
32.42%
Holding current value
$810,714
Previous $704 Million
19.48%
% of portfolio
0.69%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
322Shares Held
89.8MCall Options Held
691KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$307 Million2.36% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$241 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$241 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$122 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$112 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $2.01B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...